- Home
- WAVE vs TXMD Comparison
WAVE vs TXMD Comparison
Compare WAVE & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAVE | TXMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4M | 24.4M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | WAVE | TXMD |
|---|---|---|
| Price | $7.98 | $2.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.3K | ★ 37.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | $436.84 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $182.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $4.52 | $0.98 |
| 52 Week High | $10.50 | $2.95 |
Technical Indicators
Market Signals| Indicator | WAVE | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 60.61 |
| Support Level | $6.92 | $2.15 |
| Resistance Level | $8.60 | $2.32 |
| Average True Range (ATR) | 0.76 | 0.14 |
| MACD | -0.26 | -0.00 |
| Stochastic Oscillator | 8.36 | 93.75 |
Price Performance
Historical ComparisonAbout WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.